Simulations Plus (NASDAQ:SLP) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS

by · The Cerbat Gem

Simulations Plus (NASDAQ:SLP – Get Free Report) announced its earnings results on Thursday. The technology company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06), Zacks reports. Simulations Plus had a negative net margin of 81.74% and a positive return on equity of 13.27%.

Simulations Plus Stock Performance

NASDAQ:SLP traded down $0.94 during mid-day trading on Thursday, hitting $18.05. 525,991 shares of the company’s stock traded hands, compared to its average volume of 296,853. The company has a fifty day moving average of $18.20 and a 200 day moving average of $16.21. Simulations Plus has a twelve month low of $12.39 and a twelve month high of $37.67. The company has a market capitalization of $363.71 million, a P/E ratio of -5.61 and a beta of 1.09.

Institutional Investors Weigh In On Simulations Plus

Institutional investors and hedge funds have recently made changes to their positions in the stock. Raymond James Financial Inc. acquired a new position in shares of Simulations Plus in the 2nd quarter valued at about $25,000. Quarry LP purchased a new position in Simulations Plus during the third quarter valued at approximately $28,000. US Bancorp DE lifted its holdings in Simulations Plus by 32.5% in the third quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock valued at $93,000 after acquiring an additional 1,513 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Simulations Plus by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after purchasing an additional 390 shares in the last quarter. Finally, PharVision Advisers LLC purchased a new stake in Simulations Plus in the 3rd quarter worth approximately $155,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently commented on SLP. Weiss Ratings restated a “sell (d-)” rating on shares of Simulations Plus in a research note on Wednesday, October 8th. KeyCorp reissued a “sector weight” rating on shares of Simulations Plus in a research report on Wednesday, October 29th. BTIG Research lowered shares of Simulations Plus from a “buy” rating to a “neutral” rating in a report on Thursday, December 18th. Cowen reiterated a “hold” rating on shares of Simulations Plus in a research note on Thursday. Finally, TD Cowen lifted their price objective on shares of Simulations Plus from $16.00 to $19.00 and gave the company a “hold” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Simulations Plus has a consensus rating of “Hold” and a consensus price target of $25.00.

View Our Latest Research Report on Simulations Plus

About Simulations Plus

(Get Free Report)

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.

Featured Stories